cas 13993-61-8|| where to buy 1,2,3,4-Tetrahydro-1,5-naphthyridine

Nom du produit:1,2,3,4-Tetrahydro-1,5-naphthyridine

IUPAC Name:1,2,3,4-tetrahydro-1,5-naphthyridine

Unité d'emballage	Stock disponible	Prix($)	Quantité
CM121909-10g	in stock	ǠǠŸ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 13993-61-8 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:13993-61-8; Formule moléculaire:C8H10N2; Point de fusion:-; Code SMILES:C12=NC=CC=C1NCCC2; Densité:

: Numéro de catalogue:CM121909; Poids moléculaire:134.18; Point d'ébullition:; N° Mdl:MFCD08444439; Stockage:

: Naphthyridines; Naphthyridine is a class of aromatic heterocyclic compounds whose chemical formula is C8H6N2. They consist of naphthalene bicyclic rings in which two carbon atoms are replaced by nitrogen atoms. There are ten isomers of naphthyridine, because naphthyridine has two benzene rings, has strong π-π conjugation, and has better luminescence properties. Common naphthyridines are 1,8-naphthyridines. There are many kinds of 1,8-naphthyridine derivatives, and they are widely used.

: GDC-1971; Protein tyrosine phosphatase SHP2 mediates RAS-driven MAPK signaling and has emerged in recent years as a target of interest in oncology, both for treating with a single agent and in combination with a KRAS inhibitor. GDC-1971 (formerly RLY-1971) is a SHP2 inhibitor currently in clinical trials in combination with KRAS G12C inhibitor divarasib (GDC-6036) for the treatment of solid tumors driven by a KRAS G12C mutation.